TCL Archive NCI Invites “Extraordinary Opportunities” For Research. Groups Planning Promotion Of Cancer Clinical Trials. May 4, 2001
TCL Archive RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment September 27, 2013
TCL Archive Chemical Industry Sues NTP Over Listing PDC As Carcinogen; Environmental Groups Join Defense June 23, 1989
TCL Archive NCI Advisors To Gain Increased Responsibility For Concept, Technical Merit Review Of Contracts December 19, 1980
